Inventor
PARCELLA KYLE E
US20 patents
⚠️ This page may combine multiple inventors who share the name “PARCELLA KYLE E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS7994171B2Aug 9, 2011
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO20 citations92
US8048887B2Nov 1, 2011
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO17 citations84
US9738653B2Aug 22, 2017
Fused furans for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO3 citations72
US10745382B2Aug 18, 2020
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO2 citations62
US8722688B2May 13, 2014
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO2 citations62
US8962651B2Feb 24, 2015
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO1 citations51
US9249152B2Feb 2, 2016
Cyano containing azabenzofuran compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations42
US10214534B2Feb 26, 2019
Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations41
US9957278B2May 1, 2018
Furopyridine compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations41
VIIV HEALTHCARE UK NO 5 LTD
6 patentsUS11541055B2Jan 3, 2023
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD3 citations72
US11505543B2Nov 22, 2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD3 citations72
US12594276B2Apr 7, 2026
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations62
US10351546B2Jul 16, 2019
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10189816B2Jan 29, 2019
Substituted pyridines as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US9938271B2Apr 10, 2018
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations41